Gilder Gagnon Howe & CO LLC Rhythm Pharmaceuticals, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $12.9 Million - $20.8 Million	-1,496,424 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $85,275 - $151,276	7,301 Added 0.49%	1,496,424 $19.5 Million
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $631,735 - $769,203	-34,111 Reduced 2.24%	1,489,123 $29.2 Million
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $23 Million - $44.9 Million	1,137,702 Added 295.1%	1,523,234 $32.4 Million
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $8.16 Million - $12.6 Million	385,532 New	385,532 $11.5 Million

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.11B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.